Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
DESPITE REPEATED ISSUES with supplies, the vaccination programme has moved through the priority list, and is now focused on those aged over 70 and people with very high risk conditions.
After a rocky start in the first three months, the health service is hoping to significantly ramp up the roll-out in the second quarter of the year.
The government still expects just under one million doses to be delivered in April, 1.25 million in May and 1.68 million in June.
As part of our Reader Q&A series, we have been breaking down the latest developments with vaccines and the roll-out in Ireland, trying to answer as many of your questions as we can.
This week, most of the questions were about how the health service will manage the roll-out of vaccines to those considered to be at very high risk of severe disease.
IDENTIFYING HIGH RISK GROUPS
The majority of the questions we received from readers related to the recent change in the sequencing list which saw patients with certain very high risk conditions moved up.
I understand the government are vaccinating people based on certain medical conditions which makes perfect sense but no one has explained who decides the severity and classification of the disease. There is no database for this information in Ireland so are we leaving this decision up to individual consultants, GPs or HSE administrators? How is this data being assimilated? Should patients contact their GP or consultant to ensure they are not overlooked or is this pointless?
Who decides between group seven and four of the vaccine roll out. Who will decide who is ‘very high risk’ and who is ‘high risk’?
Why only now is HSE trying to find who is vulnerable in the community after three months it was known that a vaccine will be available?
My mother is 90 years old and she is bed-bound. Her medical condition is life threatening and to transport her to a medical centre could exacerbate her condition. How will she get her vaccine?
Last month the Minister for Health announced an update to the vaccine allocation strategy, based on a recommendation from the National Immunisation Advisory Committee (NIAC).
He said based on national and international evidence on underlying conditions that may increase the risk of severe disease or death, NIAC had been able to more comprehensively identify those conditions, to “distinguish between those which place a person at very high or high risk of severe disease if they contract the virus”.
A new ‘Cohort 4′ was created on the priority list; people aged 16-69 who are at very high risk of severe disease.
Here’s the full list of Cohort 4 conditions, with the specific patient criteria for each:
Cancer
All cancer patients actively receiving (and/or within 6 weeks of receiving) systemic therapy with cytotoxic chemotherapy, targeted therapy, monoclonal antibodies or immunotherapies and radical surgery or radiotherapy for lung or head and neck cancer.
All patients with advanced/metastatic cancers.
Chronic kidney disease
Chronic kidney disease, on dialysis, or eGFR 40 Kg/m2.
Chronic neurological disease or condition
Chronic neurological disease or condition with evolving ventilatory failure (requiring non-invasive ventilation), for example: motor neurone disease, spinal muscular atrophy.
Chronic respiratory disease
For example: severe cystic fibrosis, severe COPD, severe pulmonary fibrosis.
Diabetes
Uncontrolled diabetes, for example: HbA1C ≥58mmol/mol.
Immunocompromised
Severe immunocompromise due to disease or treatment, for example:
Transplantation: Listed for solid organ or haematopoietic stem cell transplant (HSCT), post solid organ transplant at any time, post HSCT within 12 months;
Genetic diseases: Autoimmune polyendocrinopathy candidiasis ecto- dermal dystrophy, inborn errors in the interferon pathway;
Treatment: Included but not limited to Cyclophosphamide, Rituximab, Alemtuzumab, Cladribine or Ocrelizumab in the last 6 months.
Inherited metabolic diseases
Disorders of intermediary metabolism/at risk of acute decompensation, for example: Maple Syrup Urine Disease.
Intellectual disability
Down Syndrome.
Obesity
BMI >40 Kg/m2.
Sickle cell disease
There is still another group, lower down on the list, of at risk groups. Those aged 18-64 who are considered at high risk – rather than at very high risk – are in Cohort 7. A full list of conditions covered in this cohort can be found here.
How they’re identified
HSE CEO Paul Reid has said due to the very high risk conditions captured in the recommendation from NIAC, it is assumed that the majority of the most at risk will be under the care or treatment of hospitals.
From initial feedback from the hospitals and community services, the HSE estimates there are around 150,000 people in this group.
Hospital groups have been asked to identify the relative populations based on definitions provided and they will then contact them. There will also be some input at a later stage from GPs, where patients are not in regular contact with a hospital, such as those with certain categories of diabetes.
The vaccination process for this cohort has already started and next week up to 20,000 people in this very high risk group are due to receive their first dose.
When asked by TheJournal.ie this week why work to identify high risk groups was not started earlier, HSE Chief Clinical Officer Dr Colm Henry said NIAC’s original document in December had a broad description and it was not until it issued its recent recommendation that it “mined much deeper into this group of people”.
“They decided to look at each of those 13 conditions and decide, in those conditions, what are the clinical criteria that would put people at very high risk,” he said.
“So the most recent document – instead of describing generally people who are high risk, because they have diabetes, or because [of] their lung disease or because they have Cystic Fibrosis – is much more specific.
For example, the timing of cancer treatment, whether it’s active, or whether it’s within six weeks; it talks about immunosuppression, in terms of specific medication; it talks about kidney disease very specifically in terms of whether you’re on dialysis, or whether you have what’s called a GFR – that’s a measure of severity of renal failure of less than 15. So the criteria that came out in the most recent documents were much more specific.
Officials expect the vaccination of this group to continue through March and April and the vaccinations will be administered in whichever setting is believed to be best for the patient. In many cases, this will be in the hospital where they receive treatment, though some may be able to go to vaccination centres.
Home-bound patients
The HSE has estimated there are up to 1,500 people aged over 70 who are home-bound.
Trained National Ambulance Service vaccinators will deliver the vaccines in people’s homes.
HSE CCO Dr Colm Henry said rather than differentiate between age groups, moving down from those aged over 85, to those aged over 80, then those aged 75+ and so on, the entire group will be done in parallel.
Advertisement
“We’re going to approach them as an entire entity, because of the numbers and because of the way the vaccine has been constituted, the ambulance service will have to plan for five, six or seven based on one vial and try to deal with it geographically,” he explained.
He said this will start in north Leinster this week, rolling out across the country in the following weeks.
PRIORITY LIST
The recent changes to the vaccination sequencing list have caused some confusion, with some readers saying they are now unclear about when they might get their vaccine:
When are the over 70s going to get their first vaccination. I am a 74-year-old widow, living alone. On receiving chemotherapy my lungs were damaged and I am now and have been for three years now on oxygen 24/7. I would imagine I am a priority case?
In relation to teachers, I would like to know approximately when can we expect to get the Covid-19 vaccine.
Although the vaccination of the ‘very high risk’ category has started now, this does not mean the roll-out to the over 70s has paused – this is continuing. Almost all over 85s have now been vaccinated and the programme will move down through the age groups with those aged 80-84 next, then people aged 75-79 and so on.
The HSE has said there is some flexibility within this. For example, if the 80-year-old spouse of an 85-year-old person accompanies them to get their vaccine, they can also be given the vaccine if the GP surgery has enough supplies.
Additionally, some GP surgeries only have small numbers of patients in this cohort on their books. If this is the case, in order to avoid wasting doses, they may vaccinate all of their over 70s in a short period of time, ahead of the wider national schedule.
A significant portion of next week’s vaccine doses will be given to people in the over 70 cohort, which is Cohort 3.
In relation to teachers, those working in education are part of Cohort 11. There is no date set out for the start of the roll-out to this particular cohort, but there are a number of large groups in society ahead of it.
Here’s what the sequencing list looks like, following the recent change in relation to high risk groups:
Cohort 1: Residents of long-term care facilities who are aged over 65.
Cohort 2: Frontline healthcare workers in direct patient contact.
Cohort 3: Those aged over 70.
Cohort 4: People aged 16-69 and at very high risk of severe Covid-19 disease.
Cohort 5: Those aged 65-69 and at high risk of severe Covid-19 disease.
Cohort 6: All others aged 65-69, other healthcare workers not in direct patient contact and workers key to the vaccination programme (these will all be done in parallel).
Cohort 7: Those aged 16-64 and at high risk of severe Covid-19 disease.
Cohort 8: Residents of long-term care facilities aged 18-64.
Cohort 9: People aged 18-64 living or working in crowded accommodation, where self-isolation/social distancing is difficult to maintain.
Cohort 10: Key workers who cannot avoid high risk of exposure such as those in food supply and public transport.
Cohort 11: Those who are essential to education, such as teachers, SNAs and childcare workers.
Cohort 12: People aged 55-64.
Cohort 13: Those in occupations important to the functioning of society, such as lecturers and people in entertainment and goods producing industries.
Cohort 14: People aged 18-54 who did not have access to the vaccine in prior phases.
Several readers are looking for the light at the end of the tunnel, wondering whether this roll-out of vaccines will mean an easing of restrictions, allowing people to move around more and mix.
Is our opening of society solely dependant on vaccinations?
If there’s an acceleration on vaccines (both supply and administrations) will there be an acceleration to open society?
We had a three-week camping trip booked for France at the end of June, I accept that this will not happen now. My question is, when will the campsites in Ireland be allowed to open? I would hope that once the high risk groups are vaccinated the country can move out of restrictions or is that a very simplistic view?
There are a number of criteria that are considered when public health officials and the government consider potential easing of restrictions. These include familiar factors such as hospitalisation and ICU numbers and the rate of transmission in the community. But the success of the vaccination programme will also be key to any relaxation of restrictions.
In the US, the Center for Disease Control and Prevention (CDC) has said people who are fully vaccinated can gather indoors with other vaccinated people, without wearing a mask or social distancing.
The recommendations also say vaccinated people can come together in the same way — in a single household — with people considered at low risk for severe disease, such as in the case of vaccinated grandparents visiting healthy children and grandchildren.
CDC director Dr Rochelle Walensky called the guidance a “first step” towards restoring normality in how people come together.
She said more activities would be cleared for vaccinated individuals once caseloads and deaths decline, more Americans are vaccinated, and as more science emerges on the ability of those who have been vaccinated to get and spread the virus.
In Ireland, we saw the first movement on restrictions linked to vaccinations this week, with the announcement that nursing home residents will be able to receive more regular visits from 22 March. Health officials have said there is a clear link between the low levels of disease in these settings currently and the vaccination of residents that has been taking place since the start of the year.
Residents will be able to have two visits per week if 80% of residents and staff at the nursing home have been vaccinated. There is no requirement to limit these visits to under an hour.
Ultimately, having the majority of the population vaccinated will be a significant factor in a return to ‘normal’. In the shorter-term, as we approach the 5 April deadline set by the government to assess the situation and the restrictions in place, the vaccination programme will not impact on those decisions.
Any easing will still depend on a significant reduction in transmission levels and hospital numbers.
Speaking earlier this week, Tánaiste Leo Varadkar said some measures that might be on the table in April are further outdoor activities like non-contact sports, a change to the 5km rule and the wider return of construction work. But any wider re-opening of society is a long way off.
“We want to get to the point where this is a virus that we can live with, that it’s like the flu – it’s there but it doesn’t force us to close down our country,” he told Galway Bay FM. “And that prospect is definitely there for this year. We could be there this summer, we could be there this autumn.
“But there are things we just don’t know. Among things we just don’t know is how long does your immunity last for after you get the vaccine? And also to what extent could the virus evolve to outwit the vaccines and become resistant to the vaccine.
“So there is a concern in the scientific community and the government would share this, that we can’t relate problems next winter, because not only could Covid come back next winter, there’s also all the other respiratory viruses.”
Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.
Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.
To embed this post, copy the code below on your site
Close
27 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic.
Please familiarise yourself with our comments policy
here
before taking part.
@Dave O’Keeffe: well there is no published plan on reopening. I’m sure there’s one on a desk somewhere. If people were treated like adults and told this then there would be increased confidence.
@Keith Richardson: no, if there was a widely publicised plan with an unpredictable pandemic and unreliable delivery schedules any changes would undermine the confidence you claim it would bring.
The fact we still likely won’t restart tourism and hospitality till June or July is just mind boggling, especially given the fact MM despite some who said it was lies when I pointed out that leaky Leo said the same thing, that he can’t say we won’t go into another lockdown after this one. And given the fact the hse management seem to have done nothing except allow the waiting list balloon and get themselves a pay rise, any extra surge from even a few covid cases over the winter months makes this likely since they now have a great excuse to cover up they barely cope any winter before covid hit. So this means a lot of small businesses and retail included as well may only have a small window to open and make some much needed money, meanwhile north will be full steam ahead open end of May.
So the AstraZeneca isnt safe to use on under 60s but is safe for under 60s who received 1st dose?? Think il pass on the second thanks. Back of the que I go lol
@Siobhan Rosemary: that silly. 1 in a million died of a blood clot that nobody knew to be looking for. That’s different now. 12 in a million died of covid here and doctors were definitely looking for it.
Loneliness, heartbreak and exhaustion: Parents begin sleepout to demand special education places
Jane Matthews
3 hrs ago
3.5k
41
Oval Office
Zelenskyy leaves White House summit after Trump claims he's 'not ready for peace'
Updated
39 mins ago
36.7k
192
New Mexico
Police 'keeping everything on the table' in deaths of Gene Hackman and wife Betsy Arakawa
Updated
21 hrs ago
104k
78
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 153 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 105 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 137 partners can use this purpose
Use limited data to select advertising 106 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 79 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 78 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 38 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 34 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 127 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 60 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 75 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 82 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 39 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 43 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 25 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 87 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 97 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 69 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 51 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 85 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 65 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say